Citation Impact
Citing Papers
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
2007 StandoutScience
Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells
2008
Effect of inhibition of multiple steps of angiogenesis in syngeneic murine pleural mesothelioma
2004
The role of awake video-assisted thoracoscopic surgery in spontaneous pneumothorax
2007
Video assisted thoracic surgery for treatment of pneumothorax and lung resections: systematic review of randomised clinical trials
2004
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
Salvage for Unsuccessful Aspiration of Primary Pneumothorax: Thoracoscopic Surgery or Chest Tube Drainage?
2008
Establishing the Diagnosis of Lung Cancer
2013 Standout
Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF‐C autocrine loops
2003
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
An epigenetic mechanism for capecitabine resistance in mesothelioma
2009
Simplified stepwise management of primary spontaneous pneumothorax: a pilot study
2006
The Role of CT Pulmonary Angiography in the Investigation of Unilateral Pleural Effusions
2013 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Endobronchial Ultrasound-Driven Biopsy in the Diagnosis of Peripheral Lung Lesions
2005
Can Quantitative CT Texture Analysis be Used to Differentiate Fat-poor Renal Angiomyolipoma from Renal Cell Carcinoma on Unenhanced CT Images?
2015
Simple aspiration versus chest-tube insertion in the management of primary spontaneous pneumothorax: a systematic review
2004
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
VEGF targets the tumour cell
2013
Cancer drug resistance: an evolving paradigm
2013 Standout
Drug development from marine natural products
2008 Standout
Therapies directed at vascular endothelial growth factor
2002
Meta-markers for the differential diagnosis of lung cancer and lung disease
2016
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
The human keratins: biology and pathology
2008 Standout
Ginger ingredients inhibit the development of diethylnitrosoamine induced premalignant phenotype in rat chemical hepatocarcinogenesis model
2010
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
New approaches for mesothelioma: Biologics, vaccines, gene therapy, and other novel agents
2002
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Machine Learning methods for Quantitative Radiomic Biomarkers
2015 Standout
Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010
2010 Standout
Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4
2003
Impact of Reconstruction Algorithms on CT Radiomic Features of Pulmonary Tumors: Analysis of Intra- and Inter-Reader Variability and Inter-Reconstruction Algorithm Variability
2016
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity
2006
Moving beyond chemotherapy: novel cytostatic agents for malignant mesothelioma
2004
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
2017 Standout
VEGF receptor expression and signaling in human bladder tumors
2003
Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer
2006
Quantification of Heterogeneity as a Biomarker in Tumor Imaging: A Systematic Review
2014
Chemotherapy for Malignant Pleural Mesothelioma
2003
Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusion
2013
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma
2015
High liposomal doxorubicin tumour tissue distribution, as determined by radiopharmaceutical labelling with 99mTc-LD, is associated with the response and survival of patients with unresectable pleural mesothelioma treated with a combination of liposomal doxorubicin and cisplatin
2014
2015
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Microenvironmental regulation of metastasis
2008 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Quantitative Computed Tomographic Descriptors Associate Tumor Shape Complexity and Intratumor Heterogeneity with Prognosis in Lung Adenocarcinoma
2015
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
2017 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Artificial intelligence in radiology
2018 Standout
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Advances in Malignant Mesothelioma
2005 Standout
Inhibition of the Met Receptor in Mesothelioma
2005
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
2016 Standout
Risk Factors Influencing Rebleeding after Bronchial Artery Embolization on the Management of Hemoptysis Associated with Pulmonary Tuberculosis
2013
Simple aspiration versus intercostal tube drainage for primary spontaneous pneumothorax in adults
2017
Diagnostic value of SCC, CEA and CYFRA 21.1 in lung cancer: a Bayesian analysis
1997
Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma
2012
Ginger and Its Constituents: Role in Prevention and Treatment of Gastrointestinal Cancer
2015 Standout
Artificial intelligence in cancer imaging: Clinical challenges and applications
2019 Standout
Combination therapy in combating cancer
2017 Standout
Results of a Phase I dose-escalating study of the antiangiogenic agent, SU5416, in patients with advanced malignancies.
2002
Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma
2008
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
2007 Standout
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Tissue-Level Thresholds for Axonal Damage in an Experimental Model of Central Nervous System White Matter Injury
2000 Standout
Works of Gianfranco Tassi being referenced
Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma
2001
Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy
2013
Clinical Significance of a Multiple Biomarker Assay in Patients with Lung Cancer
1990
Second Italian Consensus Conference on Malignant Pleural Mesothelioma: State of the art and recommendations
2012
Minithoracoscopy *
2003
Talcage by medical thoracoscopy for primary spontaneous pneumothorax is more cost-effective than drainage: a randomised study
2002
Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma
2000
Prognostic significance of presence and reduplication of basal lamina in malignant pleural mesothelioma
2000
Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma
2000
Indicators predictive of success of embolisation: analysis of 88 patients with haemoptysis.
2003